LSD-Assisted Psychotherapy: Reopening the Doors of Perception
After a nearly 40-year moratorium, a controlled study of the therapeutic use of LSD in humans has been published in The Journal of Neural and Mental Disease after the pioneering work of Swiss psychiatrist Peter Gasser. Sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) and approved by the BAG (the Swiss Drug Enforcement Agency), the study has completed treatment of all subjects after having enrolled its first patient in April of 2008. Many hallucinogens, such as psilocybin and MDMA, are being investigated today for their clinical benefits as a result of a gradual effort to reexamine the pharmacologic and psychiatric interests in hallucinogens.




